FDAnews
www.fdanews.com/articles/73679-bradley-signs-copromotion-agreement-with-mission

BRADLEY SIGNS COPROMOTION AGREEMENT WITH MISSION

June 27, 2005

Bradley Pharmaceuticals today announced that an agreement has been signed with Mission Pharmacal, a privately held pharmaceutical company specializing in women's health, to co-promote AnaMantle HC Cream (lidocaine HCl 3 percent/hydrocortisone acetate 0.5 percent), a clean, neat and disposable therapy used for the anti-inflammatory and anesthetic relief of discomfort due to hemorrhoids, to OB/GYN physicians.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=251082&categoryid=10)